The Media Database That Really Understands Journalists

Explore Our Database And See What Journalists Create So You Can Better Connect 🫶

Find Out More
Login
Free Trial

Media Database Chimeric Therapeutics ASX: CHM

Chimeric Therapeutics ASX: CHM
chimeric

1318 followers

Australia

The ASX Leader in #CellTherapy #CLTXCART #Chlorotoxin #NKCells $CHM

Topics
Recent articles
ASX:CHM - Investor webinar
Oct 24, 2024
chimerictherapeutics.com
ASX:CHM - Dose finding complete in ADVENT-AML Phase 1b clinical trial
Oct 23, 2024
chimerictherapeutics.com
ASX:CHM - Annual Report 2024
Oct 21, 2024
chimerictherapeutics.com
ASX:CHM - $5 million Placement to progress CHM CDH17 trial
Oct 20, 2024
chimerictherapeutics.com
ASX:CHM - AML patient achieves Complete Response in CHM CORE-NK trial
Oct 06, 2024
chimerictherapeutics.com
ASX:CHM - Achieve Clinics collaboration to expand reach of CHM CDH17
Sep 24, 2024
chimerictherapeutics.com
ASX:CHM - University of Pennsylvania joins CHM CDH17 Phase 1/2 trial
Sep 10, 2024
chimerictherapeutics.com
ASX:CHM - First patient dosed in Phase 1/2 trial of CHM CDH17
Aug 27, 2024
chimerictherapeutics.com
ASX:CHM - Phase 1/2 CHM CDH17 CAR-T GMP Manufacturing Complete
Aug 15, 2024
chimerictherapeutics.com
ASX:CHM - Chimeric receives $1.5 M advance on FY24 R&D tax incentive
Aug 12, 2024
chimerictherapeutics.com

Find out everything there is to know

Publication resume, most loved topics, and more. Find out everything there is to know about a journalist, in our 500k+ database.

Start a free trial of BuzzSumo.

START YOUR FREE TRIAL

Already registered? Log in to your account